The primary objectives of this study are to •investigate the relative bioavailability of a single oral dose of 20 mg finerenone suspension and 20 mg crushed and resuspended tablet in comparison to 20 mg finerenone tablet in the fasting condition •investigate the effect of a high fat, high calorie meal on the pharmacokinetics after a single oral dose of 20 mg finerenone suspension •investigate whether 20 mg finerenone suspension and 20 mg crushed and resuspended tablet are palatable and swallowable